Dor — Oncológica

termo de indexação original: Pain - Cancer

O acervo do Cannabis Indica reúne 109 estudos científicos que tocam a condição Dor — Oncológica, publicados entre 1975 e 2024. Pela leitura automatizada, 80 (73%) foram classificados como favoráveis, 19 (17%) como inconclusivos e 10 (9%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (60 estudos), seguido de ensaio clínico (16). Os compostos mais presentes são THC Farmacêutico, THC:CBD Farmacêutico e Tetraidrocanabinol (THC). Aparece com frequência ao lado de Dor, Câncer e Náusea e Vômito.

Estudos indexados: 109
Período coberto: 1975–2024
Favoráveis: 80 · 73%
Inconclusivos: 19 · 17%
Desfavoráveis: 10 · 9%
Termo original: Pain - Cancer

O acervo em números

Tipo de estudo

Metanálise60

Ensaio Clínico16

Metanálise Clínica15

Ensaio Clínico Duplo-Cego8

Estudo em Animais5

Estudo Laboratorial5

Direção do resultado

Favorável80

Inconclusivo19

Desfavorável10

Por década

1970s1

1990s1

2000s5

2010s42

2020s60

Aparece junto com

Dor104 Câncer55 Náusea e Vômito34 Dor — Crônica28 Dor — Neuropatia Periférica24 Insônia e Distúrbios do Sono23 Náusea e Vômito por Quimioterapia21 Ansiedade19

109 estudos

Filtrar e buscar no acervo →

2024
The role of cannabinoids in chronic pain management: clinical insights and challenges
InconclusivoMetanáliseDor Inflamação Dor — Crônica+4
2023
A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History
DesfavorávelMetanáliseDor Câncer Inflamação Tetraidrocanabinol (THC)Canabigerol (CBG)+13
2023
Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms
DesfavorávelMetanálise ClínicaDor — Crônica Dor — Aguda Dor — Neuropatia Periférica+6
2023
Cannabidiol-Loaded Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Paclitaxel-Induced Peripheral Neuropathy
FavorávelEstudo LaboratorialCâncer Inflamação Estresse Oxidativo THC Farmacêutico+12
2023
Cannabinoids for symptom management in children with cancer: It's complicated
InconclusivoMetanáliseDor Câncer Náusea e Vômito por Quimioterapia
2023
Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis
InconclusivoMetanálise ClínicaDor Dependência Química Câncer+15
2023
Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report
DesfavorávelMetanáliseDor Efeitos Adversos da Cannabis Disfunção Cognitiva Tetraidrocanabinol (THC)Canabinoide Sintético (não especificado)+9
2023
Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma
FavorávelEstudo LaboratorialDor Câncer Estresse Oxidativo Canabinoides Sintéticos AM-x Canabinoides Sintéticos WIN-x+3
2023
Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients
FavorávelMetanálise ClínicaDor THC:CBD Farmacêutico
2023
Evidence-Based Treatment of Pain in Chemotherapy-Induced Peripheral Neuropathy
FavorávelMetanáliseDor Dor — Neuropatia Periférica
2023
MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events
DesfavorávelMetanáliseDor Efeitos Adversos da Cannabis
2023
Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
FavorávelMetanáliseDor Câncer Dor — Crônica THC Farmacêutico CBD Farmacêutico+16
2022
Attitudes and Beliefs of Cancer Patients Demanding Medical Cannabis Use in the North of Thailand
FavorávelMetanáliseDor Câncer Ansiedade+5
2022
Biophysical Studies and In Vitro Effects of Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes
FavorávelEstudo LaboratorialDor Câncer Náusea e Vômito Tetraidrocanabinol (THC)+3
2022
Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials
FavorávelMetanáliseDor Câncer Endocanabinoide (não especificado)
2022
Cannabis Use and the Endocannabinoid System: A Clinical Perspective
InconclusivoMetanáliseDor Efeitos Adversos da Cannabis Dependência — Cannabis Anandamida (AEA)Tetraidrocanabinol (THC)+19
2022
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
FavorávelMetanáliseDor Câncer Náusea e Vômito
2022
Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences
FavorávelEstudo em AnimaisDor Dor — Neuropatia Periférica Náusea e Vômito por Quimioterapia Anandamida (AEA)Endocanabinoide (não especificado)+3
2022
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
FavorávelMetanáliseDor Câncer Efeitos Adversos da Cannabis Anandamida (AEA)Endocanabinoide (não especificado)+19
2022
Essential oils as anticancer agents: Potential role in malignancies, drug delivery mechanisms, and immune system enhancement
FavorávelMetanáliseDor Câncer Inflamação+1
2022
Experience With Medical Marijuana for Cancer Patients in the Palliative Setting
FavorávelMetanáliseDor Câncer Dor — Crônica+2
2022
Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD)
FavorávelEstudo LaboratorialDor Câncer Ansiedade+3
2022
In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center
FavorávelMetanáliseDor Câncer Ansiedade+14
2022
Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
FavorávelMetanáliseDor Câncer Inflamação Tetraidrocanabinol (THC)Endocanabinoide (não especificado)+13
2022
Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain
FavorávelEnsaio ClínicoDor Câncer Dor — Crônica Canabinol (CBN)Ácido Canabidiólico (CBD-a)+6
2022
Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know
FavorávelMetanáliseDor Câncer Epilepsia Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+14
2022
Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?
InconclusivoMetanálise ClínicaDor Dor — Crônica Esclerose Múltipla+1
2022
Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?
FavorávelMetanáliseDor Câncer Estresse Oxidativo Anandamida (AEA)Tetraidrocanabinol (THC)+14
2022
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes
FavorávelMetanáliseDor Ansiedade Depressão+1
2021
A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction
FavorávelEnsaio ClínicoDor Dependência — Opioides
2021
A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options
DesfavorávelMetanáliseDor Câncer Efeitos Adversos da Cannabis Canabinoide Sintético (não especificado)THC Farmacêutico+5
2021
An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models
InconclusivoMetanáliseDor Câncer Estresse Oxidativo Endocanabinoide (não especificado)+2
2021
Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials
InconclusivoMetanálise ClínicaDor Dor — Crônica Dor — Aguda THC Farmacêutico THC:CBD Farmacêutico+5
2021
Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews
InconclusivoMetanálise ClínicaDor Dor — Crônica Dor — Aguda+4
2021
Cannabis and pain: a scoping review
InconclusivoMetanáliseDor Dor — Crônica Dor — Aguda
2021
Cannabis consumption in young adults with cancer: descriptive study
FavorávelMetanáliseDor Câncer Ansiedade+3
2021
Cannabis-induced oceanic boundlessness
FavorávelEnsaio ClínicoDor Depressão Dependência — Álcool+2
2021
Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis
FavorávelEnsaio ClínicoDor Câncer Dor — Neuropatia Periférica
2021
Effectiveness of complementary therapies for the management of symptom clusters in palliative care in pediatric oncology: a systematic review
FavorávelMetanáliseDor Câncer Ansiedade+1
2021
Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients
FavorávelMetanáliseDor Câncer Insônia e Distúrbios do Sono+1
2021
International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management
FavorávelMetanáliseDor Dor — Crônica Dor — Aguda+5
2021
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey
FavorávelMetanáliseDor Câncer Insônia e Distúrbios do Sono+2
2021
Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
InconclusivoMetanáliseDor Câncer Ansiedade+5
2021
Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
InconclusivoMetanálise ClínicaDor Dor — Crônica Insônia e Distúrbios do Sono
2021
Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions
DesfavorávelMetanáliseDor Dependência Química Efeitos Adversos da Cannabis 2-Araquidonoilglicerol (2-AG)Canabinoide Sintético (não especificado)+24
2021
Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies
InconclusivoMetanáliseDor Dor — Crônica Dependência — Opioides+3
2021
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years" accumulated evidence from clinical trials
FavorávelMetanálise ClínicaDor Dor — Crônica Doenças Neurodegenerativas THC:CBD Farmacêutico+5
2020
A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults
InconclusivoMetanálise ClínicaDor Dor — Crônica Esclerose Múltipla+3
2020
Cannabidiol in cancer treatment
FavorávelMetanáliseDor Câncer
2020
Cannabidiol Oil-Associated Microscopic Colitis
DesfavorávelMetanáliseDor Inflamação Efeitos Adversos da Cannabis Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
2020
Cannabinoids use in adolescents and young adults with cancer: a single-center survey
FavorávelMetanáliseDor Câncer Ansiedade+1
2020
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study
FavorávelEnsaio ClínicoDor Dor — Crônica Esclerose Múltipla Tetraidrocanabinol (THC)Canabinol (CBN)+3
2020
Clinically Significant Drug-Drug Interaction Between Methadone and Cannabidiol
DesfavorávelMetanáliseDor Câncer Câncer — Metastático
2020
Patterns of Medical Cannabis Use Among Older Adults from a Cannabis Dispensary in New York State
InconclusivoMetanáliseDor Câncer Dor — Crônica+1
2020
Potential therapeutic treatments of cancer-induced bone pain
FavorávelMetanáliseDor Câncer
2020
Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction
DesfavorávelMetanáliseDor Câncer Câncer — Mama
2020
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial
FavorávelEnsaio Clínico Duplo-CegoDor Esclerose Múltipla THC:CBD Farmacêutico
2020
The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis
FavorávelMetanálise ClínicaDor THC Farmacêutico THC:CBD Farmacêutico
2020
The Efficacy of Medical Marijuana in the Treatment of Cancer-Related Pain
FavorávelMetanáliseDor Dependência — Opioides Cuidados Paliativos
2020
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
FavorávelEstudo em AnimaisDor Câncer Câncer — Mama 2-Araquidonoilglicerol (2-AG)Monoacilglicerol Lipase (MAGL)+1
2019
A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety
InconclusivoMetanáliseDor Câncer Epilepsia CBD Farmacêutico+1
2019
An Integrated Review of Cannabis and Cannabinoids in Adult Oncologic Pain Management
FavorávelMetanáliseDor
2019
Cannabinoids: a new approach for pain control?
FavorávelMetanáliseDor
2019
Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology
FavorávelMetanáliseDor Ansiedade Náusea e Vômito+1
2019
Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma
FavorávelEstudo em AnimaisDor Câncer Câncer — Mama Canabinoides Sintéticos WIN-x+2
2019
Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomized controlled trials
InconclusivoMetanálise ClínicaDor Dependência — Opioides THC Farmacêutico
2019
Management of chronic pain with Jalaprakshalana (water-wash) Shodhita (processed) Bhanga (Cannabis sativa L.) in cancer patients with deprived quality of life: An open-label single arm clinical trial
FavorávelEnsaio ClínicoDor
2019
Naturally occurring compounds as pancreatic cancer therapeutic
FavorávelMetanáliseDor Câncer Insônia e Distúrbios do Sono+2
2019
Position paper on medical cannabis and cannabis-based medicines in pain medicine
InconclusivoMetanáliseDor Dor — Crônica
2019
Using Cannabis to Treat Cancer-Related Pain
FavorávelMetanáliseDor Câncer
2018
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
FavorávelMetanáliseDor Câncer Inflamação Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
2018
Cannabis Use, Lung Cancer, and Related Issues
FavorávelMetanáliseDor Câncer Ansiedade THC Farmacêutico+3
2018
Medical use of cannabis: Italian and European legislation.
FavorávelMetanáliseDor Ansiedade Esclerose Múltipla THC Farmacêutico THC:CBD Farmacêutico+9
2018
Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain
FavorávelMetanáliseDor Dor — Crônica Náusea e Vômito+1
2018
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.
FavorávelEstudo em AnimaisDor Canabinoides Sintéticos SR-x
2018
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
FavorávelMetanáliseDor Dor — Crônica Dor — Neuropatia Periférica Tetraidrocanabinol (THC)THC Farmacêutico+3
2018
Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis
FavorávelEnsaio ClínicoDor Câncer Dor — Crônica+6
2018
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain.
FavorávelEnsaio Clínico Duplo-CegoDor Tetraidrocanabinol (THC)THC:CBD Farmacêutico
2018
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial
FavorávelEnsaio Clínico Duplo-CegoDor Insônia e Distúrbios do Sono Anorexia (perda de apetite)THC Farmacêutico+4
2017
A selective review of medical cannabis in cancer pain management.
FavorávelMetanáliseDor Tetraidrocanabinol (THC)THC:CBD Farmacêutico
2017
Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients
FavorávelEnsaio ClínicoDor Dor — Crônica
2017
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications
FavorávelMetanáliseDor Ansiedade Insônia e Distúrbios do Sono+2
2017
Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study
FavorávelMetanáliseCâncer Náusea e Vômito
2017
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.
FavorávelMetanáliseDor Dependência Química Dependência — Opioides Tetraidrocanabinol (THC)THC Farmacêutico+8
2017
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies
InconclusivoMetanálise ClínicaDor Tetraidrocanabinol (THC)THC:CBD Farmacêutico
2016
Integrating cannabis into clinical cancer care
FavorávelMetanáliseDor Câncer Náusea e Vômito THC:CBD Farmacêutico+10
2016
Simultaneous Activation Of Induced Heterodimerization Between CXCR4 Chemokine Receptor And Cannabinoid Receptor 2 (CB2) Reveal A Mechanism For Regulation Of Tumor Progression
FavorávelEstudo LaboratorialDor Câncer HIV/AIDS Canabinoides Sintéticos AM-x Canabinoides Sintéticos JWH-x+3
2016
β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties.
FavorávelMetanáliseDor Câncer Inflamação+16
2015
Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial
InconclusivoEnsaio Clínico Duplo-CegoDor Câncer Insônia e Distúrbios do Sono THC Farmacêutico+5
2015
Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.
FavorávelMetanáliseDor Câncer Doenças Cardiovasculares (DCV)+9
2014
Effectiveness of the Association N-Palmitoylethanolamine and Transpolydatin in the Treatment of Primary Dysmenorrhea
FavorávelEnsaio ClínicoDor — Aguda Gestação Distúrbios Menstruais Palmitoiletanolamida (PEA)
2013
A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain
FavorávelEnsaio ClínicoDor Câncer Ansiedade THC:CBD Farmacêutico+5
2013
Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs
FavorávelEstudo em AnimaisDor Câncer Psicose THC Farmacêutico+10
2012
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics
FavorávelEnsaio ClínicoDor Câncer Ansiedade Endocanabinoide (não especificado)THC Farmacêutico+10
2012
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
FavorávelEnsaio ClínicoDor Efeitos Adversos da Cannabis Dependência — Cannabis THC:CBD Farmacêutico Canabinol (CBN)+9
2012
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial
FavorávelEnsaio Clínico Duplo-CegoDor Câncer Dor — Crônica THC:CBD Farmacêutico+2
2012
Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems
FavorávelEnsaio ClínicoDor Dependência — Opioides Dor — Aguda Endocanabinoide (não especificado)
2012
Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis
FavorávelEnsaio ClínicoDor Dor — Crônica Diabetes Palmitoiletanolamida (PEA)+4
2012
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
FavorávelMetanáliseDor Esclerose Múltipla Náusea e Vômito Tetraidrocanabinol (THC)THC Farmacêutico+4
2011
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
FavorávelEnsaio Clínico Duplo-CegoDor Câncer Inflamação THC Farmacêutico+9
2011
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy
FavorávelEnsaio Clínico Duplo-CegoDor Dor — Neuropatia Periférica Câncer — Mieloma Palmitoiletanolamida (PEA)
2010
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
FavorávelEnsaio Clínico Duplo-CegoDor Tetraidrocanabinol (THC)
2008
Management of bone metastases
FavorávelMetanáliseDor Câncer Câncer — Mama THC:CBD Farmacêutico+8
2008
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
FavorávelMetanálise ClínicaDor Náusea e Vômito por Quimioterapia THC Farmacêutico
2007
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine
FavorávelEnsaio ClínicoDor Insônia e Distúrbios do Sono Esclerose Múltipla THC:CBD Farmacêutico+3
2006
The emerging role of cannabinoid neuromodulators in symptom management.
FavorávelMetanálise ClínicaDor Câncer Náusea e Vômito THC Farmacêutico+1
2001
Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
DesfavorávelMetanálise ClínicaDor — Crônica Dor — Aguda
1997
Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).
FavorávelMetanáliseDor Câncer Náusea e Vômito THC Farmacêutico+8
1975
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
FavorávelEnsaio ClínicoDor

Continue por aqui

Canabinoides e compostos

THC Farmacêutico 24 THC:CBD Farmacêutico 23 Tetraidrocanabinol (THC) 14 Endocanabinoide (não especificado) 9 2-Araquidonoilglicerol (2-AG) 9 Anandamida (AEA) 7 CBD Farmacêutico 6 Canabinoides Sintéticos WIN-x 5

Sistemas do corpo

Sistema Nervoso 59 Saúde Mental e Emocional 7 Sistema Digestório 7 Sistema Reprodutor 4 Sistema Endócrino 2 Pele e Anexos 2

Perguntas frequentes

Quantos estudos sobre dor — oncológica estão indexados no acervo?

São 109 estudos, publicados entre 1975 e 2024. O acervo inteiro tem 7.640 registros.

Que tipos de estudo predominam?

Metanálise: 60 · Ensaio Clínico: 16 · Metanálise Clínica: 15 · Ensaio Clínico Duplo-Cego: 8 · Estudo em Animais: 5 · Estudo Laboratorial: 5. A classificação segue o desenho declarado na fonte.

O que significa a classificação de resultado?

É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 80 favoráveis, 19 inconclusivos e 10 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Dor — Oncológica — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/dor-oncologica/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Dor — Oncológica — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/dor-oncologica/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.